Literature DB >> 24373349

Advances in allergic skin disease, anaphylaxis, and hypersensitivity reactions to foods, drugs, and insects in 2013.

Scott H Sicherer1, Donald Y M Leung2.   

Abstract

This review highlights some of the research advances in anaphylaxis; hypersensitivity reactions to foods, drugs, and insects; and allergic skin diseases that were reported in the Journal in 2013. Studies on food allergy suggest that (1) 7.6% of the US population is affected, (2) a "healthy" early diet might prevent food allergy, (3) the skin might be an important route of sensitization, (4) allergen component testing might aid diagnosis, (5) the prognosis of milk allergy might be predictable through early testing, (6) oral or sublingual immunotherapy show promise but also have caveats, and (7) preclinical studies show promising alternative modes of immunotherapy and desensitization. Studies on eosinophilic esophagitis show a relationship to connective tissue disorders and that dietary management is an effective treatment for adults. Markers of anaphylaxis severity have been determined and might inform potential diagnostics and therapeutic targets. Insights on serum tests for drug and insect sting allergy might result in improved diagnostics. Genetic and immune-mediated defects in skin epithelial differentiation contribute to the severity of atopic dermatitis. Novel management approaches to treatment of chronic urticaria, including use of omalizumab, are being identified.
Copyright © 2013 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved.

Entities:  

Keywords:  AD; Atopic dermatitis; Dermatology; EoE; Eosinophilic esophagitis; FPIES; Food protein–induced enterocolitis syndrome; Galactose-α-1,3-galactose; LCT; Long-chain triglyceride; MCT; Medium-chain triglyceride; OFC; OIT; OR; OVA; Odds ratio; Oral food challenge; Oral immunotherapy; Ovalbumin; PAF; Platelet-activating factor; Regulatory T; SLIT; SPT; Skin prick test; Sublingual immunotherapy; Treg; WT; Wild-type; allergy; anaphylaxis; atopic dermatitis; drug; food; hypersensitivity disorders; insect venom; skin disease; urticaria; α-Gal

Mesh:

Year:  2013        PMID: 24373349     DOI: 10.1016/j.jaci.2013.11.013

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  12 in total

Review 1.  The Other Itch That Rashes: a Clinical and Therapeutic Approach to Pruritus and Skin Picking Disorders.

Authors:  Sören A Craig-Müller; Jason S Reichenberg
Journal:  Curr Allergy Asthma Rep       Date:  2015-06       Impact factor: 4.806

Review 2.  Child with atopic dermatitis.

Authors:  Watcharoot Kanchongkittiphon; Jonathan M Gaffin; Wanda Phipatanakul
Journal:  Ann Allergy Asthma Immunol       Date:  2015-01       Impact factor: 6.347

Review 3.  The atopic march: current insights into skin barrier dysfunction and epithelial cell-derived cytokines.

Authors:  Hongwei Han; Florence Roan; Steven F Ziegler
Journal:  Immunol Rev       Date:  2017-07       Impact factor: 12.988

4.  NOD2 and TLR2 ligands trigger the activation of basophils and eosinophils by interacting with dermal fibroblasts in atopic dermatitis-like skin inflammation.

Authors:  Delong Jiao; Chun-Kwok Wong; Huai-Na Qiu; Jie Dong; Zhe Cai; Man Chu; Kam-Lun Hon; Miranda Sin-Man Tsang; Christopher Wai-Kei Lam
Journal:  Cell Mol Immunol       Date:  2015-09-21       Impact factor: 11.530

5.  Clinical Characteristics of Inpatients with Anaphylaxis in China.

Authors:  Rui Tang; Han-Yi Xu; Ju Cao; Shi Chen; Jin-Lu Sun; Hong Hu; Hai-Chao Li; Ying Diao; Zhi Li
Journal:  Biomed Res Int       Date:  2015-05-04       Impact factor: 3.411

6.  IL-33 promotes gastrointestinal allergy in a TSLP-independent manner.

Authors:  H Han; F Roan; L K Johnston; D E Smith; P J Bryce; S F Ziegler
Journal:  Mucosal Immunol       Date:  2017-06-28       Impact factor: 7.313

7.  Genome mapping of seed-borne allergens and immunoresponsive proteins in wheat.

Authors:  Angéla Juhász; Tatiana Belova; Chris G Florides; Csaba Maulis; Iris Fischer; Gyöngyvér Gell; Zsófia Birinyi; Jamie Ong; Gabriel Keeble-Gagnère; Amudha Maharajan; Wujun Ma; Peter Gibson; Jizeng Jia; Daniel Lang; Klaus F X Mayer; Manuel Spannagl; Jason A Tye-Din; Rudi Appels; Odd-Arne Olsen
Journal:  Sci Adv       Date:  2018-08-17       Impact factor: 14.136

8.  Mapping the effects of drugs on the immune system.

Authors:  Brian A Kidd; Aleksandra Wroblewska; Mary R Boland; Judith Agudo; Miriam Merad; Nicholas P Tatonetti; Brian D Brown; Joel T Dudley
Journal:  Nat Biotechnol       Date:  2015-11-30       Impact factor: 54.908

9.  Safety of an extended-release injectable moxidectin suspension formulation (ProHeart® 12) in dogs.

Authors:  Matthew J Krautmann; Sean Mahabir; Ann Fielder; Wendy Collard; Tracie L Wolthuis; Kevin Esch; Tracy Morton; Kent Alleman; Laibin Luo; Erin McCandless; Steven Nederveld; Kristina Kryda; Ryan Carroll; Joseph F Boucher
Journal:  Parasit Vectors       Date:  2019-09-06       Impact factor: 3.876

10.  Single B-cell deconvolution of peanut-specific antibody responses in allergic patients.

Authors:  Ramona A Hoh; Shilpa A Joshi; Yi Liu; Chen Wang; Krishna M Roskin; Ji-Yeun Lee; Tho Pham; Tim J Looney; Katherine J L Jackson; Vaishali P Dixit; Jasmine King; Shu-Chen Lyu; Jennifer Jenks; Robert G Hamilton; Kari C Nadeau; Scott D Boyd
Journal:  J Allergy Clin Immunol       Date:  2015-07-04       Impact factor: 10.793

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.